(10-394) Incidence of Adverse Events in Dapagliflozin vs Empagliflozin in Patients with Type 2 Diabetes at Brightwood Health Center

Wednesday, December 10, 2025

11:00 AM - 12:00 PM

Location: Bayside A, Level 1

Residency Program: Baystate Medical Center
Residency Program Type: PGY1 (Community-Based Pharmacy)
Residency Program Location: Massachusetts

Co-Author(s): Nina Devine, Erika Prouty

Primary Author(s)

Madeline Fore, PharmD, RPh

PGY-1 Community-Based Pharmacy Resident
Baystate Medical Center